Form 4 for AUPH Aurinia Pharmaceuticals Inc.
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0001600620-24-000028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-29 | 2024-02-27 | AUPH | Knappertz Volker | EVP, Research, Development | S - Sale | $6.10 | -4,930 | 319.1K | -2% | -$30.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-27 | S | D | 4,930 | $6.10 | 319,128 | D | — | — |